Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1(RS)-baclofen, naltrexone hydrochloride and D-sorbitol3件: Baclofen,
Naltrexone (Naltrexone Hydrochloride and Bupropion Hydrochloride Extended-Release),
Sorbitol		3件: Sorbitol solution ,
Baclofen ,
Naltrexone (Naltrexone) 💬 		5件: GABBR1,
GABBR2,
OPRD1,
OPRK1,
OPRM1 💬 		9件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 10 💬
24.5 mg Naltrexone1件: Naltrexone (Naltrexone Hydrochloride and Bupropion Hydrochloride Extended-Release)1件: Naltrexone (Naltrexone) 💬 3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
3Low dose naltrexone1件: Naltrexone (Naltrexone Hydrochloride and Bupropion Hydrochloride Extended-Release)1件: Naltrexone (Naltrexone) 💬 3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬2件: 96, 97 💬
4Low-dose naltrexone1件: Naltrexone (Naltrexone Hydrochloride and Bupropion Hydrochloride Extended-Release)1件: Naltrexone (Naltrexone) 💬 3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
5NAL----2件: 6, 299 💬
6Nalbuphine1件: Nalbuphine (Nalbuphin)1件: Nalbuphine (Nalbuphine) 💬 3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 85 💬
7Nalbuphine ER1件: Nalbuphine (Nalbuphin)1件: Nalbuphine (Nalbuphine) 💬 3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 85 💬
8Nalbuphine Extended-Realease (ER) Tablets1件: Nalbuphine (Nalbuphin)1件: Nalbuphine (Nalbuphine) 💬 3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 85 💬
9Nalbuphine Extended-Release (ER) Tablets1件: Nalbuphine (Nalbuphin)1件: Nalbuphine (Nalbuphine) 💬 3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 85 💬
10NALBUPHINE HYDROCHLORIDE1件: Nalbuphine (Nalbuphin)1件: Nalbuphine (Nalbuphine) 💬 3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 85 💬
11Nalmefene1件: Nalmefene (Nalmefeno)1件: Nalmefene (Nalmefene) 💬 3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
12Naloxone1件: Naloxone (Pentazocine and naloxone hydrochlorides)1件: Naloxone (Naloxone, DBL Naloxone) 💬 3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬2件: 6, 226 💬
13NALOXONE HYDROCHLORIDE1件: Naloxone (Pentazocine and naloxone hydrochlorides)1件: Naloxone (Naloxone, DBL Naloxone) 💬 3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
14NALOXONE HYDROCHLORIDE DIHYDRATE1件: Naloxone (Pentazocine and naloxone hydrochlorides)1件: Naloxone (Naloxone, DBL Naloxone) 💬 3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
15Naltrexone1件: Naltrexone (Naltrexone Hydrochloride and Bupropion Hydrochloride Extended-Release)1件: Naltrexone (Naltrexone) 💬 3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬12件: 6, 10, 13, 40, 41, 42, 43, 44, 45, 96, 97, 226 💬
16NALTREXONE CLORIDRATO1件: Naltrexone (Naltrexone Hydrochloride and Bupropion Hydrochloride Extended-Release)1件: Naltrexone (Naltrexone) 💬 3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 10 💬
17NALTREXONE HYDROCHLORIDE1件: Naltrexone (Naltrexone Hydrochloride and Bupropion Hydrochloride Extended-Release)1件: Naltrexone (Naltrexone) 💬 3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬8件: 10, 40, 41, 42, 43, 44, 45, 96 💬
18Naltrexone-HCl1件: Naltrexone (Naltrexone Hydrochloride and Bupropion Hydrochloride Extended-Release)1件: Naltrexone (Naltrexone) 💬 3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 96 💬
19Oxycodone naloxone prolonged release tablets2件: Naloxone (Pentazocine and naloxone hydrochlorides),
Oxycodone (Nalocet)		2件: Oxycodone ,
Naloxone (Naloxone, DBL Naloxone) 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
20Oxycodone/naloxone prolonged release t3件: Manganese citrate,
Naloxone (Pentazocine and naloxone hydrochlorides),
Oxycodone (Nalocet)		2件: Oxycodone ,
Naloxone (Naloxone, DBL Naloxone) 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
21Oxycodone/Naloxone Prolonged Release tablets2件: Naloxone (Pentazocine and naloxone hydrochlorides),
Oxycodone (Nalocet)		2件: Oxycodone ,
Naloxone (Naloxone, DBL Naloxone) 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
22Oxycodone/naloxone prolonged release tablets 10 mg /5 mg3件: Manganese citrate,
Naloxone (Pentazocine and naloxone hydrochlorides),
Oxycodone (Nalocet)		2件: Oxycodone ,
Naloxone (Naloxone, DBL Naloxone) 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
23Oxycodone/naloxone prolonged release tablets 10/5 mg3件: Manganese citrate,
Naloxone (Pentazocine and naloxone hydrochlorides),
Oxycodone (Nalocet)		2件: Oxycodone ,
Naloxone (Naloxone, DBL Naloxone) 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
24Oxycodone/naloxone prolonged release tablets 20 mg /10 mg3件: Manganese citrate,
Naloxone (Pentazocine and naloxone hydrochlorides),
Oxycodone (Nalocet)		2件: Oxycodone ,
Naloxone (Naloxone, DBL Naloxone) 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
25Oxycodone/naloxone prolonged release tablets 20/10 mg3件: Manganese citrate,
Naloxone (Pentazocine and naloxone hydrochlorides),
Oxycodone (Nalocet)		2件: Oxycodone ,
Naloxone (Naloxone, DBL Naloxone) 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
26Oxycodone/naloxone prolonged release tablets 5 mg /2.5 mg3件: Manganese citrate,
Naloxone (Pentazocine and naloxone hydrochlorides),
Oxycodone (Nalocet)		2件: Oxycodone ,
Naloxone (Naloxone, DBL Naloxone) 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
27Oxycodone/naloxone prolonged release tablets 5/2.5 mg3件: Manganese citrate,
Naloxone (Pentazocine and naloxone hydrochlorides),
Oxycodone (Nalocet)		2件: Oxycodone ,
Naloxone (Naloxone, DBL Naloxone) 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬